Clinical Trial Update: Optimizing Dosing of Colistin for Infections Resistant to All Other Antibiotics, Approved NIH Protocol Dated 12.06.07(DMID Protocol #07-0036) [NA]

View source ↗

Summary

A completed NIH-supported clinical trial update focusing on optimizing colistin dosing for infections resistant to all other antibiotics.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacteremia
• Pseudomonas Infections

Drugs mentioned

• Colistin (colistin)

Snippet

Sponsor: University of Pittsburgh | Conditions: Bacteremia, Pseudomonas Infections | NA | Status: COMPLETED